Green Synthesis, Characterization and Antimicrobial Activity of Silver Nanoparticles (AGNPS) From Maize (Zea Mays L)
dc.contributor.author | Eren, A. | |
dc.contributor.author | Baran, M. F. | |
dc.date.accessioned | 14.07.201910:50:10 | |
dc.date.accessioned | 2019-07-16T20:42:31Z | |
dc.date.accessioned | 2025-09-17T14:28:08Z | |
dc.date.available | 14.07.201910:50:10 | |
dc.date.available | 2019-07-16T20:42:31Z | |
dc.date.available | 2025-09-17T14:28:08Z | |
dc.date.issued | 2019 | |
dc.description.abstract | In recent years, the biosynthesis (green synthesis) of metal nanoparticles such as silver nanoparticles (AgNPs) have become one of the safest, most cost-effective and environmentally friendly approaches. In this study, AgNPs were synthesized using maize (Zea mays L.) leaves. For the characterization of synthesized AgNPs different techniques were used, such as X-ray diffraction spectroscopy (XRD), Ultraviolet visible (UV-Vis) spectroscopy, transmission electron microscopy (TEM), Energy dispersive X-ray spectroscopy (EDX), Fourier-transformed infrared spectroscopy (FT-IR) and Thermal gravimetric and Differential thermal analysis (TGA-DTA). The XRD results showed that AgNPs had a mean diameter of 12.63 nm and a crystal-like appearance. In addition, antimicrobial activities of synthesized AgNPs were evaluated using 3 different antibiotics against Gram-negative Escherichia coli and Gram-positive Staphylococcus aureus bacteria and Candida albicans yeast. Antifungal activity of AgNPs with antibiotics has been observed to be better than the antibiotics against Gram-positive and Gram-negative bacteria. The minimum inhibitory concentrations were found to be 0.084, 0.337 and 0.021 mg mL(-1) for Escherichia coli, Staphylococcus aureus, and Candida albicans, respectively. The results revealed that AgNPs synthesized from maize leaf extract have antibacterial activity against Gram-negative Escherichia coli, Gram-positive Staphylococcus aureus and antifungal activity against Candida albicans yeast, and that the produced AgNPs could be used in the production of biomedical products and in the pharmaceutical industry. | en_US |
dc.identifier.doi | 10.15666/aeer/1702_40974105 | |
dc.identifier.issn | 1589-1623 | |
dc.identifier.issn | 1785-0037 | |
dc.identifier.scopus | 2-s2.0-85064352620 | |
dc.identifier.uri | https://doi.org/10.15666/aeer/1702_40974105 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12514/9416 | |
dc.indekslendigikaynak | Scopus | en_US |
dc.language.iso | en | en_US |
dc.publisher | Aloki Applied Ecological Research and Forensic inst Ltd | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.subject | Antimicrobial Activity | en_US |
dc.subject | Green Agnps | en_US |
dc.subject | Escherichia Coli | en_US |
dc.subject | Staphylococcus Aureus | en_US |
dc.subject | Candida Albicans | en_US |
dc.title | Green Synthesis, Characterization and Antimicrobial Activity of Silver Nanoparticles (AGNPS) From Maize (Zea Mays L) | en_US |
dc.type | Article | en_US |
dspace.entity.type | Publication |